Health Condition 1: K00-K95- Diseases of the digestive system
Conditions
Interventions
Intervention1: Drug:Dexmedetomidine: Route: Intravenous
Dose: 0.5mcg/kg/hr
Intervention2: Drug:Dexmedetomidine with Ketamine: Route: Intravenous
Dose: 0.3mcg/kg/hr and 0.3mg/kg/hr respectively
Control
Sponsors
ILBS
Eligibility
Inclusion criteria
Inclusion criteria: ASA class 1 & 2
Exclusion criteria
Exclusion criteria: Patient refusal Contraindication to study drugs History of drug abuse Insufficient comprehension to use of PCA ASA class 3 & 4
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To compare the postoperative fentanyl consumption for the first 24 hours using IV PCA in following two groups of patients undergoing major abdominal surgery Group A Intraoperative IV dexmedetomidine infusion Group B Intraoperative IV ketodex infusion Timepoint: Post Operative 24hr | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare the intraoperative anesthetic requirementsTimepoint: End of Surgery;To compare the intraoperative fentanyl requirementsTimepoint: End of surgery;To compare the postoperative pain scores using NRSTimepoint: 0,2,4,12,24hrs;To compare the time of first rescue analgesia requirementTimepoint: Post Operative;To record incidence of post operative nausea and vomitingTimepoint: Post Operative;To record incidence of post operative delirium using CAM ICU scoreTimepoint: post operative;- To compare the postoperative sedation score using the Modified Ramsay Sedation Scale(MRSS)Timepoint: postoperative;To compare the intraoperatively hemodynamic parametersTimepoint: 15mins | — |
Countries
India
Contacts
Public ContactDr Udit Dhingra
Institute of Liver and Biliary Sciences
Outcome results
None listed